Anxiety News and Research

Latest Anxiety News and Research

Gene linked to PMDD and other maladies during menstrual cycle

Scientists have identified a gene they say is a strong candidate for involvement in premenstrual dysphoric disorder (PMDD) and other maladies associated with the natural flux in hormones during the menstrual cycle. In a paper to be published today in the Proceedings of the National Academy of Sciences, Rockefeller University researchers detail experiments in mice showing that a common human variant of the gene increases anxiety, dampens curiosity and tweaks the effects of estrogen on the brain, impairing memory.

9 Feb 2010

IHHS website provides medical resources for people suffering from dermatologic disorder

Therese has suffered with a dermatologic disorder called Hyperhidrosis since she was six years old, leaving her with perpetually wet hands and feet.

9 Feb 2010

Finding provides new insight into economic behavior of human beings

Neuroscientists at the California Institute of Technology (Caltech) and their colleagues have tied the human aversion to losing money to a specific structure in the brain-the amygdala.

9 Feb 2010

A novel way to identify color choice in healthy, anxious and depressed individuals

People with anxiety and depression are most likely to use a shade of gray to represent their mental state. Researchers writing in the open access journal BMC Medical Research Methodology describe the development of a color chart, The Manchester Color Wheel, which can be used to study people's preferred pigment in relation to their state of mind.

9 Feb 2010

Women with low levels of income are susceptible to anxiety and depression after diagnosed with DCIS

A new analysis has found that women with medium or low levels of income are particularly susceptible to anxiety and depression after being diagnosed with the precancerous breast condition, ductal carcinoma in situ (DCIS).

8 Feb 2010

APA urges Pentagon and Congress to end restrictions on gays and lesbians serving in military

The American Psychological Association urged both the Pentagon and Congress today to move swiftly to end the restrictions on gays and lesbians serving openly in the military, noting that there are decades of scientific research demonstrating no threat to military readiness or morale.

5 Feb 2010

Personalized risk assessment tools can help improve smoking cessation

Giving smokers information about their own individual risk of serious illness helps motivate them to quit smoking, according to a paper published in the current issue of Postgraduate Medical Journal.

5 Feb 2010

Neuroscience research and clinical care launched at UT Medical School

Innovative neuroscience research and expanded clinical care have been launched at the new Center of Excellence on Mood Disorders at The University of Texas Medical School at Houston.

4 Feb 2010

Regular physical activity prevents chronic illness: Surgeon General urged to make outdoor time a health priority

National Wildlife Federation (NWF), more than 200 health, conservation, youth, and other organizations, and 16,300 Americans are urging the new surgeon general to make time outdoors a health priority for children.

4 Feb 2010

Study shows Cymbalta reduces chronic low back pain

In a new study, 60 mg of Cymbalta® (duloxetine HCl) taken once daily significantly reduced chronic low back pain, as measured by the Brief Pain Inventory (BPI) average pain rating, compared with placebo.

3 Feb 2010

FDA approves Labopharm's OLEPTRO antidepressant for MDD

Labopharm Inc. today announced the U.S. Food and Drug Administration (FDA) has approved OLEPTRO(TM) (trazodone hydrochloride) Extended Release Tablets, a novel once-daily formulation of the antidepressant trazodone, for the treatment of major depressive disorder (MDD) in adults. OLEPTRO(TM) utilizes CONTRAMID(R), Labopharm's clinically validated technology that controls the release of active substances within oral medications.

3 Feb 2010

Penn Medicine experts available to offer medical insight and commentary during 2010 Winter Olympics

Experts from the University of Pennsylvania School of Medicine are available to offer expert medical insight and commentary during the 2010 Winter Olympics in Vancouver on issues ranging from the effects of performance enhancing drugs to concerns about the spread of novel H1N1, head trauma and more.

3 Feb 2010

Persons with impaired hearing should be encouraged by family members to seek appropriate treatment

Recent data arising out of the Better Hearing Institute's "MarkeTrak" national study demonstrates that hearing loss is prevalent, serious, and often denied by the sufferer. The information revealed suggests that family members of the hearing impaired should actively encourage their loved ones to address their hearing problem, an effort which will greatly benefit both the hard of hearing and their kin.

2 Feb 2010

GlaxoSmithKline's Lamictal XR Extended-Release Tablets receive FDA approval

laxoSmithKline announced today that the U.S. Food and Drug Administration has approved Lamictal®XR™ (lamotrigine) Extended-Release Tablets as once-a-day, add-on therapy for epilepsy in patients ages 13 years and older with primary generalized tonic-clonic seizures.

29 Jan 2010

NIDA supports Omeros' Addiction program

Omeros Corporation today announced that the National Institute on Drug Abuse (NIDA) is providing support for the Company's Addiction program. NIDA will fund substantially all of the costs of a Phase 2 clinical study to be conducted by New York State Psychiatric Institute researchers.

28 Jan 2010

Blocking CRF may prevent excessive alcohol consumption

A team of scientists from The Scripps Research Institute has found that a specific stress hormone, the corticotropin-releasing factor (CRF), is key to the development and maintenance of alcohol dependence in animal models.

28 Jan 2010

Pfizer's new pipeline shows growth and diversity in research and development

Pfizer Inc. today provided an update to its pipeline for the first time since the close of the acquisition of Wyeth in October, 2009. The new development pipeline, composed of assets from both legacy companies, includes 133 programs from phase 1 through registration, and shows growth and increased diversity in each of the areas where the company invests in research and development.

28 Jan 2010

Anxiety News and Research

Latest Anxiety News and Research

Gene linked to PMDD and other maladies during menstrual cycle

IHHS website provides medical resources for people suffering from dermatologic disorder

Finding provides new insight into economic behavior of human beings

A novel way to identify color choice in healthy, anxious and depressed individuals

Women with low levels of income are susceptible to anxiety and depression after diagnosed with DCIS

APA urges Pentagon and Congress to end restrictions on gays and lesbians serving in military

Personalized risk assessment tools can help improve smoking cessation

Neuroscience research and clinical care launched at UT Medical School

Regular physical activity prevents chronic illness: Surgeon General urged to make outdoor time a health priority

Study shows Cymbalta reduces chronic low back pain

FDA approves Labopharm's OLEPTRO antidepressant for MDD

Penn Medicine experts available to offer medical insight and commentary during 2010 Winter Olympics

Persons with impaired hearing should be encouraged by family members to seek appropriate treatment

GlaxoSmithKline's Lamictal XR Extended-Release Tablets receive FDA approval

NIDA supports Omeros' Addiction program

Blocking CRF may prevent excessive alcohol consumption

Pfizer's new pipeline shows growth and diversity in research and development

NCHC Action Fund calls for redoubling efforts to enact comprehensive health system reform

FDA approves FIRST RESPONSE Early Result Pregnancy Test

Discovery could help improve diagnosis and treatment for anxiety disorders

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Anxiety News and Research

Latest Anxiety News and Research

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Newsletters you may be interested in